Analyst calls FDA's rejection of cholesterol drug a 'major ... | 29 Apr 08, 14:02

Home | Support

Headline News:

Drug Testing

Analyst calls FDA's rejection of cholesterol drug a 'major ...

29 Apr 08, 14:02

By Dan Gallagher & John Letzing, MarketWatch SAN FRANCISCO (MarketWatch) -- Merck & Co. saw its share price drop more than 7% Tuesday morning on the news ...

more